Covid-19 After Q4 Earnings Calls: Comparing Industry Outlook and Physician Perspectives During Q4 earnings calls, biopharmaceutical companies reflected on the cumulative impact of the COVID-19 pandemic. An assessment of US-based physician sentiment (n=62) provides a useful ‘on-the-ground’ perspective to further examine these issues.
